Literature DB >> 23489552

Diuretic-induced hyponatremia and osteoporotic fractures in patients admitted to the emergency department.

Spyridon Arampatzis1, Lena-Maria Gaetcke, Georg-Christian Funk, Christoph Schwarz, Markus Mohaupt, Heinz Zimmermann, Aristomenis Konstantinos Exadaktylos, Gregor Lindner.   

Abstract

OBJECTIVE: Hyponatremia is a complication of diuretic treatment and has been recently identified as a novel factor associated with osteoporosis and fractures. The impact of diuretic-associated electrolyte disorders on osteoporotic fractures (OF) has rarely been studied systematically. DESIGN AND
SETTING: We conducted a study in patients presenting to the emergency department at the University Hospital Bern. In this retrospective case series analysis of prospectively gathered data, over a 2-year period we identified 10,823 adult (≥50 years) outpatients with a measured baseline serum sodium, at admission to the hospital. OF patients were compared to a control group without fractures using standard statistical methods.
RESULTS: Four hundred and eighty (5%) patients had 547 OF. The OF group had a higher mean age (73 vs. 68 years, p<0.0001), smaller proportion of men (37% vs. 58%, p<0.0001), higher hospitalisation rate (83% vs. 62%, p<0.0001) and longer hospital stay (8 vs. 6 days, p<0.0001). Any diuretic agent (p<0.0001), loop diurietics (p=0.02), spironolactone (p=0.02) and amiloride (p<0.01) were used significantly more in OF patients, but not thiazides (p=0.68). The prevalence of hyponatremia increased significantly (p<0.0001) with the number of diuretics taken. Advanced age (odds ratio [OR] 1.04, p<0.0001), hyponatremia (OR 1.46, p=0.011) higher serum creatinine (OR 1.53, p=0.0001), furosemide use alone (OR 1.40, p=0.01) and co-treatment with amiloride (OR 2.22, p=0.02) were associated with a higher risk for OF.
CONCLUSIONS: This study highlights the clinical association of hyponatremia during the use of certain diuretics (i.e. furosemide or in combination, i.e. amiloride) with an increased risk of osteoporosis associated fractures. Although evidence-based data is currently lacking a pragmatic approach concerning hyponatremia monitoring and correction appears reasonable in selected groups of patients.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23489552     DOI: 10.1016/j.maturitas.2013.02.007

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  16 in total

Review 1.  Tolerability of Antihypertensive Medications in Older Adults.

Authors:  Thiruvinvamalai S Dharmarajan; Lekshmi Dharmarajan
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

Review 2.  Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis.

Authors:  Mahua Ghosh; Sumit R Majumdar
Journal:  Endocrine       Date:  2014-02-07       Impact factor: 3.633

3.  Hyponatremia and Fractures: Findings From the MrOS Study.

Authors:  Sophie A Jamal; Spyridon Arampatzis; Stephanie Litwack Harrison; Roxana C Bucur; Kristine Ensrud; Eric S Orwoll; Douglas C Bauer
Journal:  J Bone Miner Res       Date:  2015-06       Impact factor: 6.741

4.  Hyponatremia and osteoporosis: reappraisal of a novel association.

Authors:  F Afshinnia; B Sundaram; R J Ackermann; K K Wong
Journal:  Osteoporos Int       Date:  2015-03-26       Impact factor: 4.507

5.  Hyponatremia Is Associated With Increased Osteoporosis and Bone Fractures in a Large US Health System Population.

Authors:  Rachel L Usala; Stephen J Fernandez; Mihriye Mete; Laura Cowen; Nawar M Shara; Julianna Barsony; Joseph G Verbalis
Journal:  J Clin Endocrinol Metab       Date:  2015-06-17       Impact factor: 5.958

6.  Commonly Prescribed and Over-the-Counter Drugs as Secondary Causes of Osteoporosis-Part Two.

Authors:  Joseph Pizzorno; Lara Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2021-06

7.  Association between loop diuretic use and fracture risk.

Authors:  F Xiao; X Qu; Z Zhai; C Jiang; H Li; X Liu; Z Ouyang; D Gu
Journal:  Osteoporos Int       Date:  2014-12-10       Impact factor: 4.507

Review 8.  [Pharmacogenic osteoporosis beyond cortisone. Proton pump inhibitors, glitazones and diuretics].

Authors:  P H Kann; P Hadji; R S Bergmann
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

9.  Hyponatremia, a risk factor for osteoporosis and fractures in women.

Authors:  J P Holm; A O S Amar; L Hyldstrup; J E B Jensen
Journal:  Osteoporos Int       Date:  2015-10-23       Impact factor: 4.507

Review 10.  Interventions for chronic non-hypovolaemic hypotonic hyponatraemia.

Authors:  Evi V Nagler; Maria C Haller; Wim Van Biesen; Raymond Vanholder; Jonathan C Craig; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2018-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.